Executive Branch

RSS Feed for this category

McConnell Puts Kibosh on Sentencing Reform [FEATURE]

Prospects for a major federal sentencing reform bill brightened on Wednesday with President Trump's announcement that he would support the effort, but by week's end, those prospects dimmed as Senate Majority Leader Mitch McConnell (R-KY) told the president he wouldn't bring the bill to a floor vote this year.

The grinch who stole sentencing reform. (Creative Commons/Gage Skidmore)
The bill is known as the First Step Act. The House passed a version of this spring, but the House version was limited to reforms on the "back end," such as slightly increasing good time credits for federal prisoners and providing higher levels of reentry and rehabilitation services.

The Senate bill crafted by a handful of key senators and pushed hard by presidential son-in-law Jared Kushner incorporates the language of the House bill, but also adds actual sentencing reforms. Under the Senate bill:

·         Thousands of prisoners sentenced for crack cocaine offenses before August 2010 (the date of the Fair Sentencing Act, which reduced, but did not eliminate sentencing disparities) would get the chance to petition for a reduced sentence.

·         Mandatory minimum sentences for some drug offenses would be lowered.

·         Life sentences for drug offenders with three convictions ("three strikes") would be reduced to 25 years.

Even though the bill has been a top priority of Kushner's and had the support of numerous national law enforcement groups and conservative criminal justice groups, as well as the support of key Democrats, such as Sen. Cory Booker (D-NJ) and Sen. Dick Durbin (D-IL), McConnell told Trump at a White House meeting Thursday that there wasn't enough time in the lame-duck session to take it up.

"McConnell said he didn't have the time, that's his way of saying this isn't going to happen," said Michael Collins, interim director of the Drug Policy Alliance's (DPA) Office of National Affairs. "McConnell was a roadblock under Obama and he's a roadblock now. He likes to hide behind the process but I think he just doesn't like or care about this issue."

McConnell's move upset what should have been a done deal, said Collins.

"Once First Step passed the House, some key figures on the Senate side, such as Sens. Durbin and Grassley, said it wouldn't move without sentencing reform, and then Kushner facilitated negotiations between the Senate and the White House and they reached broad agreement this summer," he recounted. "Then the question was can we get this to the floor? McConnell sat down with Grassley and Durbin and said after the elections, and Trump agreed with that. The idea was that if Trump would get on board, McConnell would hold a vote, would whip a vote. He wanted 60 votes; there are 60 votes. Then McConnell said the Senate has a lot to do. At the end of the day, it's up to McConnell. When Trump endorsed people thought it would move McConnell, but he just poured cold water on it."

That means sentencing reform is almost certainly dead in this Congress. And as long as Mitch McConnell remains Senate Majority Leader, he will be an impediment to reform.

"McConnell is the obstacle—it's not Tom Cotton (R-AR) or Jeff Sessions—it's McConnell, and he's going to be there next year and the year after that," said Collins. "He is the prime obstacle to criminal justice reform, even though a lot of groups on the right are in favor of this. Since he isn't going to listen to us, it's going to be up to them to figure this out."

"If McConnell doesn't prioritize this, it doesn't happen," said Kara Gotsch, director of strategic initiatives for the Sentencing Project, a Washington, D.C.-based advocacy group. That's a shame, she said, because "I'm optimistic both parties would support this if they got the chance."

But now it doesn't look like they will get that chance. That's the downside. But there is a possible upside: Failure to pass limited criminal justice reform this year may lead to a bill next year that goes further than limited sentencing reforms.

"It's been a long, hard slog to get to where we are," said Collins, "but now some people are saying this compromise stuff gets us nowhere and we should be doing things like enacting retroactivity for sentencing reforms, eliminating all mandatory minimums for drug offenses, and decriminalizing all drugs."

"My job is to continue to beat the drum for change," said Gotsch. "It's always hard, and we don't get those opportunities a lot. Momentum doesn't come very often, regardless of who is in power, and we can't let these small windows close without doing our best to move the ball forward. This has been my concern for 20 years—the conditions these prisoners face, the injustice—and we will keep pushing. The federal prison system is in crisis."

The federal prison population peaked at 219,000 in 2013, driven largely by drug war prosecutions, and has since declined slightly to about 181,000. But that number is still three times the number of federal prisoners behind bars when the war on drugs ratcheted up under Ronald Reagan in the 1980s. There is still lots of work to be done, but perhaps next time, we demand deeper changes. 

This article was produced by Drug Reporter, a project of the Independent Media Institute.

The Drug Policy Alliance is a financial supporter of Drug Reporter.

Chronicle AM: "Dozens" of Underground Safe Injection Sites in Seattle, NJ Pot Votes Coming, More... (11/15/18)

A local activist reveals that "dozens" of unpermitted safe injection sites are operating in the Seattle area, New Jersey legislative leaders say marijuana legalization will see votes this month, and more.

Vancouver's (legal) Insite safe injection site (vch.ca)
Marijuana Policy

GAO Scolds DEA over Marijuana Eradication Program. In a report released Wednesday, the Government Accountability Office (GAO) criticized the Drug Enforcement Administration (DEA) over failings in its marijuana eradication program. GAO charged that DEA failed to collect sufficient documentation from state and local law enforcement agencies that partnered with DEA in the program, a fault that could prevent DEA from accurately assessing program performance. Furthermore, DEA "has not clearly documented all of its program goals or developed performance measures to assess progress toward those goals," the report found.

New Jersey Legislative Leaders Say Vote on Marijuana Legalization Coming This Month. Assembly Speaker Craig Coughlin and Senate President Steve Sweeney said Wednesday the legislature would move on marijuana legalization this month. Coughlin said he had the votes in committee to pass legislation, while Sweeney said he needed help from Gov. Phil Murphy (D) to pick up necessary votes in the Senate. "The only way something like this gets passed legislatively is if all three of us work together," Sweeney said. "If (the governor's office is) not going to lobby any votes for us then it won't get done."

Wisconsin Legislator Will Be Back With a Legalization Bill Next Year. State Rep. Melissa Sargent (D-Madison) said Wednesday that she will once again file a marijuana legalization bill when the legislature convenes in January. Sargent has filed legalization bills every year since 2014 but has renewed momentum after voters in 16 counties and two towns voted for legalization in non-binding referenda in the midterms. "The facts clearly show that legalization is right for Wisconsin and that the most dangerous thing about marijuana is that it's illegal," she said.

Harm Reduction

"Dozens" of Underground Safe Injection Sites Are Operating in the Seattle Area. Harm reduction activist Shilo Jama has told a local media outlet that "dozens" of unpermitted safe injection sites are operating in Seattle and surrounding King County. "They're slowly developing their own culture and their own service. It's a lot like the speakeasies of old where you've got to know someone to be invited in. You need the password or some kind of information that you're not, kind of, out to get them," Jama said. Seattle and King County authorities are moving toward officially allowing such facilities, but local harm reduction activists aren't waiting.

Chronicle AM: Trump Endorses Prison Reform Bill, Cities Call for MJ Rescheduling, More... (11/14/18)

President Trump has given his endorsement to a limited bipartisan prison reform bill, the National League of Cities calls for marijuana rescheduling, and more.

President Trump has given his endorsement to the First Step Act. (Creative Commons/Gage Skidmore)
Marijuana Policy

National League of Cities Calls For Federal Marijuana Rescheduling. The National League of Cities, representing more than 19,000 cities, towns, and villages across the country, has passed a pair of resolutions on marijuana policy. The first calls on the Trump administration and Congress to "resolve the conflict between state and federal cannabis laws" and "provide guidance to financial institutions that results in the cannabis market having access to the federally regulated banking system," while the second calls for marijuana to be removed from the list of Schedule I drugs under the Controlled Substances Act.

Medical Marijuana

Bipartisan Lawmaker Group Files Three Veterans' Medical Marijuana Bills. A bipartisan group of legislators on Wednesday announced plans to file a trio of bills aimed at making the Department of Veterans Affairs a more marijuana-friendly agency. The Department of Veterans Affairs Policy for Medicinal Cannabis Use Act of 2018 would clarify the already existing policy of protecting patients who discuss their marijuana history. The Department of Veterans Affairs Survey of Medicinal Cannabis Use Act of 2018 would conduct a nationwide survey of all veterans and VA healthcare providers regarding medicinal cannabis. And the Department of Veterans Affairs Medicinal Cannabis Education Act of 2018 would have the VA work with medical universities to further develop medicinal cannabis education programs for primary healthcare providers.

Law Enforcement

Trump Endorses Prison Reform Bill. In a press conference Wednesday, President Trump gave his support to a limited prison and sentencing reform bill, the First Step Act (HR 5682). The bill invests heavily in anti-recidivism efforts and lowers some mandatory minimum sentences, but has not gone as far as some Democrats would like. In the House, 57 Democrats voted against it because it did not more substantially address sentencing reform. Now, in the Senate, it will face opposition from some conservative Republican senators, but the president's endorsement should help propel it forward.

Chronicle AM: Fed Sentencing Reform Bill Looms, HHS Recommends Kratom Ban, More... (11/13/18)

Congress could move on both sentencing reform and industrial hemp in the lame duck session, HHS recommends banning kratom, Thailand moves to legalize and regulate both kratom and medical marijuana, and more.

Despite spending $8 billion to suppress the poppy crop, the situation in Afghanistan is "worse than ever," a new report finds.
Sentencing Reform

Federal Sentencing Reform Bill Set to Advance. Key senators have reached a tentative agreement on a major criminal justice reform bill that is being supported by presidential advisor and Trump son-in-law Jared Kushner. The proposed legislation would boost rehabilitation efforts for federal prisoners and give judges more discretion when sentencing nonviolent offenders, particularly for drug offenses. The measure has support from both liberal and conservative groups, ranging from the ACLU to the Fraternal Order of Police and groups supported by the Koch brothers.

Marijuana Policy

Michigan Prosecutors Start Dropping Marijuana Cases. Local prosecutors are beginning to announce the dropping of charges in pending marijuana cases after voters last week voted to legalize the drug. Genesee County Prosecutor David Leyton said last Friday that "there will no longer be any prosecutions for possession or use of marijuana" in his jurisdiction, and other DAs are expected to follow suit.

Texas Lawmaker Files Marijuana Decriminalization Bill. State Rep. Joe Moody (D-El Paso) has prefiled a marijuana decriminalization bill for the 2019 legislative session. "Civil penalty legislation is the first thing I've filed on the first day of filing for the 86th Session. There's been an incredible swell of bipartisan support since last session, and the official Texas Republican and Democratic platforms both approve of this kind of reform now," Moody said in a press release. "I'm optimistic that this will be the session we finally see smarter, fairer marijuana laws in Texas."

Medical Marijuana

Connecticut Adds Chronic Neuropathic Pain to List of Qualifying Conditions. The General Assembly's Regulations Review Committee has agreed that chronic neuropathic pain associated with degenerative spinal disorders is eligible for treatment with the drug. That makes it the 31st specific condition considered a qualifier for medical marijuana.

Industrial Hemp

McConnell Says Hemp Provision Will Be in Farm Bill. Senate Majority Leader Mitch McConnell (R-KY) said Friday that completing work on a new farm bill is a top priority and that a provision to fully legalize hemp cultivation will be included.

Kratom

HHS Recommends Banning Kratom. The Department of Health and Human Services has recommended that kratom be placed in Schedule I of the Controlled Substances Act. HHS sent a letter to the DEA saying that two chemicals in the herbal supplement should be Schedule I. The recommendation is in line with past public statements from FDA Commissioner Scott Gottlieb, who calls kratom "an opioid" and says it has been "associated" with dozens of deaths.

International

Thai Congress Proposes Legalizing Kratom, Medical Marijuana. The National Legislative Assembly has officially proposed allowing the licensed use of medical marijuana and kratom. The two drugs would be placed in a legal category that would allow their licensed possession and distribution. The Health Ministry will review the proposal before submitting it to the cabinet, which could amend it before returning it to the legislature. The entire process could be completed by year's end.

Foreign Policy

Afghan Opium Problem "Worse Than Ever," Inspector General's Report Finds. Despite the US spending more than $8 billion to reduce opium cultivation in Afghanistan, the problem is "worse than ever," a new report from the Special Inspector General for Afghanistan Reconstruction (SIGAR) finds. "No counterdrug program undertaken… by the United States, its coalition partners, or the Afghan government resulted in lasting reductions in poppy cultivation or opium production," the report stated.

Good Riddance! Drug Reformers Applaud Sessions’ Departure from DOJ [FEATURE]

Former Attorney General Jeff Sessions was forced out of office Wednesday after less than two years in office, and while there is intense concern about the impact the move could have on ongoing investigations of Trump campaign and administration misdeeds, for drug and criminal justice reform advocates that concern is leavened by joy and relief at the forced exit of a man who staunchly promoted harsh and repressive drug and criminal justice policies.

Jeff, we hardly knew ye. (senate.gov)
Even as marijuana reform spread across the land and support for the tough sentencing practices of last century's drug war waned, Sessions strode bravely backward as attorney general. Among the lowlights of his tenure:

  • He escalated the war on drugs by ordering federal prosecutors to seek the toughest charges and sentences for drug offenses, a harsh return to some of the worst excesses of the drug war, one quite out of the mainstream of even Republican sentencing policy thinking these days.

  • He escalated the war on drugs by undoing Obama-era restrictions on federal asset forfeiture and restarting destructive asset forfeiture practices. His actions on asset forfeiture basically gave state and local law enforcement agencies a green light to evade state forfeiture laws by handing cases off to the feds in return for a massive cut of the proceeds.

  • He at least formally reversed the Obama administration's "live and let live" approach to marijuana reforms in the states, undoing the Cole memo that directed federal prosecutors to leave state law-compliant pot operations alone. But Sessions' anti-marijuana crusade ended up a quixotic quest, with even President Trump suggesting an openness to legal weed and leaving Sessions spinning in the wind.

  • He ignored harm reduction principles and best practices aimed at reducing drug overdoses and the spread of blood-borne disease by threatening to crack down on safe injection sites, facilities where drug users can shoot up under medical supervision that also serve as a nexus between problematic users and treatment and social services.

  • He undermined the work of the department's Civil Rights Division, particularly by moving to end the use of consent decrees that subject police departments troubled by brutality or discrimination to federal oversight.

Even some key Republican senators rejected his retrograde approach on marijuana and sentencing reform and have criticized his resort to civil asset forfeiture. While in the Senate, Sessions was one of the biggest obstacles to sentencing reform, and since he left, bipartisan support for drug policy reform has continued to grow. It's probably too much to expect progressive policies from anyone Trump appoints to replace Sessions, but it's hard to see getting someone more regressive.

The National Organization for the Reform of Marijuana Laws (NORML) minced no words in its assessment of Sessions.

"Attorney General Jefferson Sessions was a national disgrace," said NORML director Erik Altieri. "NORML hopes that he finds the time during his retirement to seek treatment for his affliction of 1950s reefer madness."

The Trump administration needs to replace Sessions with someone more in tune with popular sentiment on marijuana, added NORML deputy director Paul Armentano.

With 33 states now recognizing the medical use of cannabis, and with 10 states having legalized the use and sales of marijuana for all adults, it is pivotal that the next US Attorney General be someone who recognizes that most Americans want cannabis to be legally regulated and that they oppose any actions from the Justice Department to interfere with these state-sanctioned efforts," he said.

The Drug Policy Alliance echoed that call.

"While Trump's dismissal of Sessions raises questions about the president's motivations, the Justice Department and Senate should seize this opportunity to right Sessions' wrongs," said DPA executive director Maria McFarland Sánchez-Moreno. "The US public understands that the drug war has failed spectacularly and needs to be replaced with a health-centered approach. It is critically important that the next attorney general be committed to defending basic rights and moving away from failed drug war policies."

Jeff Sessions: A man whose time has come -- and gone.

This article was produced by Drug Reporter, a project of the Independent Media Institute.

Drug Policy Alliance is a financial supporter of both Drug Reporter and Drug War Chronicle.

Chronicle AM: NYC Marijuana Busts Way, Way Down; New Federal Fentanyl Sentences in Effect, More... (11/9/18)

New York City marijuana possession arrests plummet (finally), Utah patients will have some legal protection beginning next month, federal fentanyl sentences just increased, and more.

a lethal dose of fentanyl (DEA.gov)
Marijuana Policy

Michigan US Attorneys Warn That Federal Prohibition Remains in Force. In a joint statement released Thursday, US Attorneys for Michigan Matthew Schneider and Andrew Birge warned that even though voters there legalized marijuana on Tuesday, "marijuana continues to be an illegal drug under federal law" and that they "will not unilaterally immunize anyone from prosecution for violating federal laws simply because of the passage of Proposal 1." That said, the federal prosecutors then conceded "our offices have never focused on the prosecution of marijuana users or low-level offenders" and that "as we weigh the interests in enforcing a law, we must also consider our ability to prosecute with our limited resources."

Arrests for Low-Level Marijuana Possession have Decreased 90 Percent Following New NYPD Marijuana Guidelines. Arrests for low-level marijuana possession have plummeted 90 percent since new NYPD marijuana enforcement guidelines took effect in September. There were 151 arrests for low-level marijuana in the entire city of New York in September 2018, less than 10 percent of the 1,500+ arrests last September and 3 percent of the 4,300+ arrests that took place in September 2010. However, racial disparities in enforcement still persist, with Blacks and Latino people comprising around 80 percent of the 1,000 summonses issued for marijuana.

Medical Marijuana

Utah Patients Will Have Legal Protections Beginning December 1. Although it could take months or years for the state to get a medical marijuana cultivation and distribution system up and running, medical marijuana patients will win some protections from arrest and prosecution beginning on December 1. That's because the Prop 2 initiative approved by voters includes an "affirmative defense" provision protecting them from a criminal conviction. It doesn't explicitly protect patients from arrest, but the hope is that with little likelihood of a successful prosecution, police will have little incentive to actually arrest patients.

Heroin and Prescription Opioids

Harsher Federal Penalties for Selling Fentanyl-Laced Drugs Are Now in Effect. New federal sentencing guidelines that went into effect November 1 significantly increase the possible prison sentence faced by people who sell heroin or cocaine laced with fentanyl. The new guidelines "create a four-level enhancement for a defendant who knowingly misrepresents or knowingly markets as another substance a mixture containing fentanyl or a fentanyl analog," which translates into sentences nearly twice as long as previously. While the guidelines only apply to someone who intentionally sought to deceive buyers, the realities of the federal criminal justice system -- where the vast majority of cases end with plea bargains -- mean that prosecutors will rarely have to prove the intent to deceive.

Chronicle AM: Sessions Out at DOJ, MA Pot Shop Sales to Begin in Mere Days, More... (11/8/18)

Jeff Sessions is no longer the attorney general, elections have consequences in New York and DC, and more.

A prohibitionist dinosaur bites the dust. (senate.gov)
Marijuana Policy

Massachusetts Marijuana Sales Likely Only Days Away After Regulators OK Labs. The state Cannabis Control Commission has cleared two licensed marijuana testing laboratories for operations, paving the way for sales to begin within a matter of days. CDX Analytics and MCR Labs received "commence full operations" notices Wednesday. The move is critical since pot shops can only sell marijuana that has been tested for purity and potency.

New York's Path to Legalization Just Got a Whole Lot Easier. Democrats took control of the state Senate in Tuesday's elections, removing a Republican-controlled Senate as a major obstacle to pushing a legalization bill through the legislature. Gov. Andrew Cuomo (D), who also won a third term in the elections, is now a proponent of legalization, and Democratic lawmakers in Albany have already proposed bills that would legalize weed. Marijuana should move next year at the statehouse.

DC Could Finally Allow Legal Pot Sales After Democrats Take House. With Democrats back in control of the House after Tuesday's elections, the path has become more promising for the District of Colombia to embrace full commercial legalization of marijuana. DC residents voted for legalization in 2014, but the Republican House has consistently blocked any moves toward creating a system of taxed and regulated marijuana commerce. At a post-Election Day news conference, Mayor Muriel Bowser reiterated her commitment to establishing a regulatory scheme for marijuana sales early next year. City council members cautioned, though, that removing congressional riders and setting up a legal weed market in the city could take at least a year.

Law Enforcement

Jeff Sessions Out as Attorney General. Attorney General Jeff Sessions resigned at President Trump's request Wednesday after less than two years in office. Sessions pursued an aggressive agenda to escalate the war on drugs by ramping up sentencing for drug offenses, restarting destructive asset forfeiture practices, and threatening crackdowns on marijuana legalization and supervised consumption services. Sessions also undermined the work of the Department's Civil Rights Division, opposing steps to hold police accountable for abuses, including killings of African Americans. Trump appointed Matthew Whitaker as acting attorney general and will now select a new AG, who must be approved by the Senate.

Medical Marijuana Update

Medical marijuana initiatives win in Missouri and Utah, the FDA approves the first marijuana-based drug, and more.

National

First FDA-Approved Marijuana-Based Drug Now Available by Prescription. As of last Thursday, the marijuana-based drug Epidiolex is now available by prescription in all 50 states. The FDA approved the drug in June, but manufacturer GW Pharmaceuticals had to wait for the DEA to reclassify its compounds out of Schedule I before it could begin selling it. That has now happened. Epidiolex is used for treating a rare form of epilepsy and a genetic brain dysfunction called Dravet syndrome, both of which can cause seizures.

Iowa

Iowa Regulators Reject Bid to Raise THC Cap on New Medications. The state's Medical Cannabinoid Board voted unanimously last Friday to rebuff an effort to raise the 3% THC cap on new medications. Proponents argued that more THC is more effective in treating some conditions, while critics worried that lifting the limit could encourage abuse. "I'd like to get another year or two under our belts and see how people respond with the current THC cap," said board member Lonny Miller, a family physician from Creston.

Missouri

Missouri Votes to Legalize Medical Marijuana. Two of three medical marijuana initiatives won on Tuesday. Amendment 3, which would have imposed a 15 percent tax and set up a research institute benefiting its author, was easily defeated, while Amendment 2 had 65.5 percent support, and Proposition C had 56.5 percent. Amendment 2 was backed by both the Marijuana Policy Project and the Drug Policy Alliance.

Utah

Utah Voters Approve Medical Marijuana. Despite the machinations of the Mormon Church and the state's Republican political establishment, which sought to blunt support for Proposition 2 by promising to pass some sort of medical marijuana bill later this year, voters weren't willing to wait. On Tuesday, Prop 2 had 53.2 percent of the votes, with 76 percent of precincts reporting. Even in Deep Red Utah, medical marijuana wins. Under this measure, people with designated qualifying conditions can obtain a medical marijuana recommendation from a doctor, but patients whose conditions aren't listed have to go through a more rigorous process. Patients won't be allowed to smoke their medicine, either. It remains to be seen what will happen with medical marijuana in the legislature.

[Drug Policy Alliance is a financial supporter of the organization that publishes this newsletter.]

[For extensive information about the medical marijuana debate, presented in a neutral format, visit MedicalMarijuana.ProCon.org.]

Chronicle AM: Weed on the Ballot in 4 States This Election Day, OH Sentencing Reform, Too, More... (11/6/18)

Marijuana policy initiatives are on the ballot in four states today, so is sentencing reform in Ohio, the FDA approves a powerful new opioid, El Chapo goes on trial in New York, and more.

Do your civic duty today. (Creative Commons)
Marijuana Policy

Marijuana Legalization, Medical Marijuana on the Midterm Ballot Today. It's not just about control of the Congress. Four states are seeing statewide marijuana policy initiatives: In Michigan and North Dakota, legalization is on the ballot; in Missouri and Utah, medical marijuana in on the ballot. Also, a number of Ohio localities are voting on decriminalization, and in Wisconsin, a number of localities will be voting on non-binding referenda on whether to legalize marijuana. Come back tomorrow for results.

Heroin and Prescription Opioids

FDA Approves Opioid Pain Reliever 1,000 Times Stronger Than Morphine. The Food & Drug Administration has approved a new opioid pain reliever that is a thousand times stronger than morphine and ten times stronger than fentanyl. The new drug, Dsuvia, will be used as a fast-acting alternative to intravenously administered opioids in hospitals. Critics warned that the new drug could be abused, but FDA Commissioner Scott Gottlieb said in a statement that it will only be used with "very tight restrictions."

Law Enforcement

El Chapo Goes on Trial in New York City. Longtime Sinaloa Cartel leader Joaquin "El Chapo" Guzman has gone on trial in New York City this week. El Chapo was extradited to the US in 2017 after escaping from a Mexican prison and being recaptured months later, and now faces a 17-count federal indictment for his role heading the cartel, including money laundering, firearms, and multiple murder charges. Although El Chapo has been out of circulation for more than a year, the Sinaloa Cartel remains arguably the most powerful of Mexican drug trafficking organizations.

Sentencing

Ohio Votes on Whether to Defelonize Drug Possession Today. Voters in the Buckeye State will have a chance to approve the Issue 1 sentencing reform initiative. The initiative would move most drug possession charges from felonies to misdemeanors. It would also allow some nonviolent offenders to receive 25% sentence reductions and would also prohibit jail time as a sentence for using or possessing drugs until the third offense within 24 months. Come back tomorrow for results.

International

Israeli Finance Minister Criticizes Delay in Approving Medical Marijuana Exports. Finance Minister Moshe Kahlon blamed the Public Security Ministry for foot-dragging on allowing exports of the herb, thus "harming Israel's economy, farmers and local industry," and called for the cabinet to act to approve exports and advance legislation. "For more than six months, the Public Security Ministry has been preventing the plan from being put on the cabinet's agenda, thereby harming Israel's economy, farmers and local industry," Kahlon wrote in a memo Monday to the cabinet secretary. "During these months a number of countries around the world, including Australia and Canada, began to export medical cannabis."

Chronicle AM: Legal MJ Shortages, Mexico to Move Toward Legal MJ Market, More... (11/3/18)

The Granite State has a new guide to marijuana legalization, ONDCP releases coca cultivation and cocaine production figures for Peru and Bolivia, Canada suffers legal pot shortages, and more.

North America is becoming a very weed-friendly continent. (Creative Commons)
Marijuana Policy

New Hampshire Commission Issues Marijuana Legalization Report. The Commission to Study the Legalization, Regulation, and Taxation of Marijuana has released its report, complete with 54 separate recommendations on how legalization should be implemented. Among them are creating a state-level Cannabis Commission to regulate it, similar to the way the state regulates alcohol. The group estimated that legalization could bring in revenue of $36.6 million a year once the market stabilizes, and possibly reaching $47 million. The report is designed to help guide any legislative moves toward legalization.

Medical Marijuana

Iowa Regulators Reject Bid to Raise THC Cap on New Medications. The state's Medical Cannabinoid Board voted unanimously last Friday to rebuff an effort to raise the 3% THC cap on new medications. Proponents argued that more THC is more effective in treating some conditions, while critics worried that lifting the limit could encourage abuse. "I'd like to get another year or two under our belts and see how people respond with the current THC cap," said board member Lonny Miller, a family physician from Creston.

Foreign Policy

ONDCP Releases Data on Coca Cultivation and Cocaine Production in Peru and Bolivia. The White House Office of National Drug Control Policy (ONDCP -- the drug czar's office) released the US government's annual estimates of coca cultivation and cocaine production for Bolivia and Peru last Friday. Although Peru produces more coca and cocaine than Bolivia, and although Peru's coca cultivation and potential cocaine production are trending up while Bolivia's are trending down, ONDCP was more critical of Bolivia. "The ongoing coca --cultivation in both Peru and Bolivia pose a threat for us as a nation, and aggravates our domestic drug addiction crisis," said ONDCP Deputy Director Jim Carroll. "It is important that our governments work together to take action against cultivation and production, and to save lives of those affected by drug trafficking. Peru continues to be a great partner and we have a shared responsibility to address this problem. In Bolivia, we would like to see real efforts against cultivation and production."

International

Canada Struggles to Meet Huge Demand for Legal Marijuana. Just two weeks after legal retail marijuana sales began, Canadian pot retailers -- both physical and online -- are having problems dealing with unexpectedly high demand. In much of the country, the legal supply has almost entirely dried up. "There is not enough legal marijuana to supply all of recreational demand in Canada," said Rosalie Wyonch, a policy analyst at the CD Howe Institute. "The shortages are happening faster than I would have expected, but our research suggested quite strongly that there would be shortages in the first year of legalization."

Colombia Announces New Strategy to Disrupt Drug Trade. Last Thursday, Colombian Attorney General Nestor Humberto Martinez announced a new "disruption policy" of going after the cocaine trade by cutting access to alkaloids and power sources in rural areas. He called for "petrochemical innovation" so that fuels stop yielding the factors needed to create cocaine hydrochloride, as well as restricting the sale of government-subsidized gasoline in cocaine and marijuana producing regions. But one analysis says the proposals "might sound innovative on paper but are unlikely to have a major impact on the drug trade and may end up hurting long-suffering residents."

Mexico's Ruling Party Plans Legislation To Legalize Marijuana Sales. Less than a week after the country's Supreme Court ruled that laws barring the personal use, possession, and cultivation of marijuana are unconstitutional, key figures in the ruling MORENA Party are already moving to craft legislation to create a legal marijuana market. First, they say, they will move to repeal the now null and void criminal laws against marijuana, and then, "We are going to take a step forward in the regulation that may already involve the production, marketing and distribution of marijuana," said Olga Sánchez Cordero, a senator who is expected to become interior secretary in the incoming government of President-elect Andrés Manuel López Obrador. "I say it from the heart: we celebrate it, the Court is setting a marvelous precedent for us to walk in that direction," Sánchez added.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safer Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School